Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients

BACKGROUND: The B-cell translocation gene 2 (BTG2) is considered to act as a tumour-suppressor gene because of its antiproliferative and antimigratory activities. Higher levels of BTG2 expression in tumour cells have been linked to a better clinical outcome for several cancer entities. Here, we inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagener, N, Bulkescher, J, Macher-Goeppinger, S, Karapanagiotou-Schenkel, I, Hatiboglu, G, Abdel-Rahim, M, Abol- Enein, H, Ghoneim, M A, Bastian, P J, Müller, S C, Haferkamp, A, Hohenfellner, M, Hoppe-Seyler, F, Hoppe-Seyler, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590653/
https://www.ncbi.nlm.nih.gov/pubmed/23299537
http://dx.doi.org/10.1038/bjc.2012.573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590653/
https://www.ncbi.nlm.nih.gov/pubmed/23299537
http://dx.doi.org/10.1038/bjc.2012.573

Ejemplares similares